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SUMMARY 
In this paper the use of a computer-controlled photodiode array spectrophotometric 
detector for the high-performance liquid chromatographic (HPLC) profiling of carboxylic 
acids in physiological fluids is reported. The ultraviolet spectrum of the flowing eluent is 
obtained at 6-set intervals and is displayed as the absorbance at 190 nm. A three-dimensional 
(time versus wavelength versus absorbance) presentation of the HPLC profile facilitates 
peak identification through ultraviolet spectrum matching and relative retention time 
comparison with carboxylic acid standards. Several rxamples of HPLC urinary csrboxylic 
acid profiles from infants with various inborn errors of metabolism are shown. 
INTRODUCTION 
The high-performance liquid chromatographic (HPLC) profiling of car- 
boxylic acids in physiological fluids is a means of distinguishing normal and 
abnormal specimens as a first approach to the detection of inborn errors of 
metabolism [1,2]. The on-column injection of filtered raw urine or plasma to 
which has been added an internal standard results in fast analyses with minimal 
sample preparation. The major drawback to this procedure is the lack of a 
means of peak identification. Both the single- [2] and the dual-column [l] 
profiling techniques result in most of the carboxylic acids eluting in the first 
6-18 min. Thus, most of the acids of interest have similar elution volumes and 
are hard to identify by peak augmentation. Wavelength ratioing may facilitate 
peak identification but generally requires one or more additional passes through 
the HPLC system. Use of a computer-controlled photodiode array spectro- 
photometer as an HPLC detector affords the UV spectra of each peak as it 
elutes. Through the use of appropriate software (see Experimental), the UV 
spectrum and its 1st and 2nd derivatives [3] can be obtained for any peak or 
portion of a peak, i.e. leading edge, apex or trailing edge. In addition, a three- 
037%4347/85/$03.30 o 1985 Elsevier Science Publishers B.V. 
24 
dimensional (time versus wavelength versus absorbance) representation of the 
chromatogram can be produced. This facilitates peak identification and the 
determination of peak purity. In this paper we report results obtained using a 
computercontrolled photodiode array spectrophotometer as a detector for 
the dual-column HPLC profiling of carboxylic acids in urine. Peak identity 
was in some cases confirmed by fraction collecting and gas chromatographic- 
mass spectrometric (GC-MS) analysis of each fraction. 
EXPERIMENTAL 
Chemicals 
All carboxylic acids were either from Aldrich (Milwaukee, WI, U.S.A.) or 
from Sigma (St. Louis, MO, U.S.A.) and were used as received. HPLC-grade 
water was from Burdick & Jackson Labs. (Muskegon, MI, U.S.A.). 
Equipment 
A Varian 5000 high-performance liquid chromatograph (Varian Assoc., 
Palo Alto, CA, US.A.) with an HP 1040 A photodiode array spectrophoto- 
metric detector (Hewlett-Packard, Palo Alto, CA, U.S.A.) interfaced with an 
HP 85 computer with a dual-disk drive was used for all determinations. An 
HP 4’770A plotter was used for all chromatograms and spectral plots. An HP 
5995 B gas chromatograph-mass spectrometer was used for all MS determina- 
tions with a 5% OV-22 glass column (1.83 m X 1/g” I.D.) (Supelco, Bellefonte, 
PA, U.S.A.) for all GC separations. 
Procedure 
Sample preparation and chromatographic conditions have been previously 
reported [l] and consisted of an HPX 87H organic acid column (Bio-Rad 
Labs., Richmond, CA, U.S.A.) in series with a 15-cm, 5 pm particle size, ODS 
column (Bio-Rad Labs.) with a mobile phase of sulfuric acid pH 2.5. The HP 
85 data disk was formated to accept 1000 records while the HP 1040 A de- 
tector was set to detect and save all spectra from 190-350 nm at a 0.80 min 
peak width. The monitor wavelength was 190 nm and the attenuation was 0.2 
a.u.f.s. for a lo-p1 injection. 
Fraction collection was accomplished by injecting either 0.50 ml or 1.00 ml 
of urine while the detector was set at 2.5 a.u.f.s. The-volume injected depended 
upon the creatinine concentration of the urine sample. Urine samples with a 
creatinine concentration from 0.25 to 1.00 mg/ml required a l.OO-ml aliquot 
to be injected onto the HPLC columns while samples with a creatinine con- 
centration >l.OO mg/ml required a 0.50-ml aliquot. Fraction collection and 
GC-MS analysis of samples having a creatinine concentration < 0.20 mg/ml 
were unsuccessful. During the first part of the run, fractions were collected at 
1-min intervals (6-22 min) while 3-min intervals were used for the duration of 
the run (23-75 min). Each fraction was rechromatographed (10 ~1 injected; 
0.1 a.u.f.s., 0.80 min peak width) to determine the number of components 
present. A three-dimensional profile (elution time versus wavelength versus ab- 
sorbance) and the UV spectrum and its 1st and 2nd derivative spectra were pro- 
duced for each peak in each fraction. Each fraction was saturated with sodium 
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chloride and extracted twice with 3 ml of ethyl acetate and once with 3 ml of 
diethyl ether. The combined organic extracts were taken to dryness under a 
stream of air and converted to the trimethylsilyl (TMS) derivative by the addi- 
tion of 30 ~1 of N,O-bis(trimethylsilyl)trifluoroacetamide (BSTFA) with 1% 
trimethylchlorosilane (TMCS) and heating for 15 min at 90°C. A l-p1 sample 
was injected into the GC-MS system. 
The GC parameters were: flow-rate: 25 ml/min; injector temperature: 
250°C; initial temperature: 90°C; temperature hold: 4 min; final temperature: 
280°C; rate of heating: 5”C/min; final temperature hold: 15 min. An electron- 
impact (EI) mass spectrum was taken for each peak and identification was by 
comparison of spectra from known standards and from published spectra of 
TMS carboxylic acid derivatives [4 3 . 
RESULTS AND DISCUSSION 
A chromatogram for an abnormal urine sample is shown in Fig. 1. Most of 
the peaks are found within the first 22 min of the run. Abnormally large 
peaks are observed at 8,12 and 14 min but their identity cannot be ascertained 
by reference to the relative retention time (RRT) alone. Using the three- 
dimensional display capability (Fig. 2A-C) of the software, we can both sepa- 
rate the peaks by varying the time axis and tentatively identify some of them. 
The peaks at 12 and 14 min are thought to be lactic acid and succinic acid, 
respectively, based on their UV spectra. Lactic acid is frequently detected 
in all patients while the succinic acid is probably of bacterial origin [4]. 
The peak at 8.2 min has the correct RRT and UV spectrum for erotic acid. 
Orotic acid is normally a minor component of urine but is markedly elevated 
Fig. 1. HPLC carboxylic acid profile from a lo-cl1 injection of urine; 190 nm; 0.200 a.u.f.s.; 
sulfuric acid pH 2.5 at 0.8 ml/min. The peak at 17.98 min is uric acid and the peak at 
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Fig. 2. Three-dimensional profile of the urine sample in Fig. 1. (A) The 5-9 min interval 
of the chromatogram; (B) the 9-15 min interval of the chromatogram; (C) the 15-22 min 
interval of the chromatogram shown in a reversed time scale so that the peak at 21 min 
(uracil) can be seen; (D) the Oth, 1st and 2nd derivative spectra of authentic erotic acid. 
in urea cycle defects [5] . The UV spectrum of the 8.2-min peak and its 1st 
and 2nd derivative spectra (Fig. 2D) match that of authentic erotic acid. 
Other components identified in the chromatogram include the 17.9%min 
peak which was shown by its UV spectrum to be uric acid [1,2] and the 
67.91-min peak which was thought to be hippuric acid by comparison of its 
UV spectra with that of authentic hippuric acid. 
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TABLE I 
IDENTIFICATION OF SOME CARBOXYLIC ACIDS FROM URINE 
Retention Relative Identity Means of identification 
time retention 
(min) time* 
6.21 0.07 Oxalic acid GC-MS 
7.92 0.09 Orotic acid uv 
9.39 0.11 Citric acid GC-MS 
Isocitric acid GC-MS 
11.60 0.14 Lactic acid UV and GC-MS 
3-Hydroxypropanoic acid GC-MS 
Succinic acid GC-MS 
14.18 0.17 Succinic acid GC-MS 
17.98 0.21 Uric acid uv 
Glutaric acid GC-MS 
Ryroglutamic acid GC-MS 
20.93 0.25 UraciI UV and GC-MS 
43.13 0.51 3-(3-Hydroxyphenyl) 
3-hydroxypropanoic acid GC-MS 
50.24 0.59 3- or 4-Hydroxyhippuric acid GC-MS 
67.91 0.80 Hippuric acid UV and GC-MS 
4-Hydroxyphenylacetic acid GC-MS 
*Internal standard (3shydroxy-4-methoxybenzyl alcohol), RRT = 1.00. 
Usually, the UV spectrum of a peak does not exactly match that of any of 
the standard acids which elute at the same RRT. This was thought to be due 
to the simultaneous elution of two or more compounds. In order to confirm 
this, we collected fractions at l-min intervals for the first 22 min of the profile 
and at 3-min intervals for the duration of the run. Each fraction was con- 
verted to the TMS derivative and analyzed by GC-MS. Our initial attempt was 
unsuccessful. However, when a larger volume of urine was analyzed (0.5-1.0 
ml), fraction collection and derivatization were successful. The injection 
volume necessary for fraction collection was dependent upon the creatinine 
concentration of the urine (see Experimental), Table I shows the results of 
fraction collection. As would be expected, there is some overlap between 
fractions. Since each fraction must be extracted and derivatized, it was ex- 
pected that not every peak (irrespective of its size in the 190-nm chromato- 
gram) could be identified by GC-MS analysis. The erotic acid and uric acid 
peaks are good examples since they both have strong absorptivity at 190 nm 
but were not identified by GC-MS analysis while the uracil peak (20.9 min) 
was identified by GC-MS. Perhaps the use of a non-extractive isolation tech- 
nique such as silicic acid absorption [6] or Extrelut columns [7] and the use 
of a capillary GC column might improve the GC-MS analysis of collected 
fractions. 
Coeluting compounds may not be detectable by UV analysis because of the 
vast differences in their molar absorptivities. Glutaric acid and pyroglutamic 
acid were found to coelute with uric acid (Table I) but were not observed in 
the UV spectrum of this peak. Coeluting compounds may also escape UV 
detection when they have the same or similar UV spectrum. The 67.91-min 
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peak of Fig. 1 has the expected RRT and UV spectrum for either hippuric 
acid or 4-hydroxyphenylacetic acid and cannot be positively identified by 
its UV spectrum. GC-MS analysis of this peak (Table I) showed that both 
compounds were present. 
Fig. 3A shows the 190~nm carboxylic acid profile of a urine sample from 
an infant with methylmalonic aciduria. The peak at 11.83 min is larger than 
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Fig. 3. (A) The 190-nm urinary HPLC carboxylic acid profile from a child with methyl- 
mslonic acidemia; the peak at 18.28 min is uric acid; (B) three-dimensional profile of the 
6-12 min interval of the chromatogram; (C) Oth, 1st and 2nd derivative UV spectra of the 
11.83-min peak; (D) 001, 1st and 2nd derivative UV spectra of authentic methylmalonic 
acid. 
normal (compare with Fig. 1). The three-dimensional plot (Fig. 3B) and the 
Oth, 1st and 2nd derivative UV spectra (Fig. 3C) of this peak indicate that it 
is methylmalonic acid. The Oth, 1st and 2nd derivative UV spectra of authentic 
methylmalonic acid are shown in Fig. 3D. 
The 190~nm urinary carboxylic acid profile shown in Fig. 4A has an ab- 
normally large peak at 8.36 min. Based upon RRT values, this peak could be 
erotic acid or 2-oxoglutaric acid. The three-dimensional plot of this peak is 
indicative of a 2-oxocarboxylic acid not erotic acid (compare Fig. 4B with 
Fig. 2B), Thus, this peak was identified as 2oxoglutaric acid. CC-MS analysis 
of the TMS derivatives of the extracted urinary organic acids showed that 





Fig. 4. (A) The 190-nm urinary carboxylic acid profile. The peak at 17.51 is uric acid while 
the peak at 62.03 min is hippuric acid and 4-hydroxyphenylacetic acid; (B) three-dimen- 
sional profile of the 5.5-10 min interval of the chromatogram. The peak at 8.36 min is 
2-oxoglutaric acid. 
As can be seen by comparing the HPLC carboxylic acid profiles in Pigs. 
1, 3A and 4A, there is some day-to-day and run-to-run variation in the elution 
volume of the compounds. Use of the photodiode array detector to produce 
the UV spectrum of each peak enables one to identify the internal standard 
(3-hydroxy4-methoxybenzyl alcohol) and thus calculate the RRT of each 
peak. 
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Successful diagnosis and treatment of newborns with catastrophic inborn 
errors of metabolism requires that the time for analysis be kept to an ab- 
solute minimum. A delay in even one or two days may result in irreparable 
brain damage in the patient while the appropriate therapeutic avenue is sought. 
Because of the limited sample preparation and the brief (70-80 min) analysis 
time, we feel that the procedures described in this paper represent a significant 
advance in the ability to detect certain inborn errors of metabolism. By per- 
mitting one to distinguish various carboxylic acids via their UV spectra, it is 
possible to arrive at a diagnosis of some inborn errors with greater rapidity 
than was previously possible using GC-MS analysis of the TMS derivatives of 
the carboxylic acids. Although this procedure does not allow the same amount 
of information to be obtained as a complete analysis of the TMS-derivatized 
carboxylic acids via GC-MS, it represents an enhanced first step which can be 
performed while the more complete analysis is undertaken. In those instances 
in which information leading to a diagnosis is possible, the delay between 
diagnosis and institution of appropriate therapy is reduced accordingly. 
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